Used in the treatment of non-small cell lung cancer and pancreatic cancer by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase. It helps block signals involved in tumor cell proliferation and survival. Commonly prescribed for patients with specific EGFR mutations, it improves progression-free survival when used as targeted therapy. Also utilized in research settings to study signaling pathways in cancer cells.